Nu Skin Enterprises logo

Nu Skin EnterprisesNYSE: NUS

Profile

Country:

United States

IPO:

22 November 1996

Next earnings report:

N/A

Last dividends:

30 August 2024

Next dividends:

N/A
$325.05 M
-88%vs. 3y high
39%vs. sector
-vs. 3y high
-vs. sector
-84%vs. 3y high
20%vs. sector
-82%vs. 3y high
15%vs. sector

Price

after hours | Fri, 01 Nov 2024 23:59:50 GMT
$6.54+$0.35(+5.65%)
$439.08 M$440.95 M
$439.08 M-$118.26 M

Analysts recommendations

Institutional Ownership

NUS Latest News

FPT and National University of Singapore Join Forces in Driving AI Innovation and Fostering Talent Development
businesswire.com21 October 2024 Sentiment: POSITIVE

SINGAPORE--(BUSINESS WIRE)--The National University of Singapore's School of Computing (NUS Computing) has entered into a partnership with FPT, a leading global technology corporation based in Vietnam, to advance the field of artificial intelligence (AI). This collaboration plans a joint investment of US$50 million, to be contributed by FPT, NUS, and other key players in the local and regional AI ecosystems over the next five years, aiming to drive pioneering research in AI and enhance talent d.

Nu Skin: Betting On A Potential Comeback
seekingalpha.com21 October 2024 Sentiment: POSITIVE

Nu Skin Enterprises is at a potential inflection point with seemingly stabilized revenue. Management's restructuring and innovative product focus, particularly through the Rhyz business, show promise for a turnaround and long-term growth. A strong balance sheet and steady cash flow support the business, reducing bankruptcy risk and enabling strategic pivots and shareholder rewards.

NUS Stock Trading Below 200 & 50-Day SMA: What Should You Do Now?
zacks.com08 October 2024 Sentiment: NEGATIVE

Nu Skin is encountering persistent macroeconomic obstacles, weighing on consumer spending and customer acquisition.

Nu Skin Enterprises to Announce Third Quarter 2024 Financial Results
businesswire.com07 October 2024 Sentiment: POSITIVE

PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release third quarter 2024 results after the market closes on Thursday, Nov. 7. The Nu Skin management team will host a conference call with the investment community later that same day at 5 p.m. ET. During the call, management will discuss recent results and upcoming business initiatives. The webcast of the conference call, including the financial information presented, will be available on the investor.

Nu Skin Trading Near 52-Week Low: Should You Buy or Sell NUS Stock?
zacks.com23 September 2024 Sentiment: NEGATIVE

Nu Skin is facing macroeconomic difficulties and a slow-moving direct-selling market. Foreign currency headwinds are also weighing on NUS.

Mavely Achieves Major Milestones: $675M+ Run Rate with Increased Growth and Creator Payouts
prnewswire.com27 August 2024 Sentiment: POSITIVE

Everyday Influencer Platform® Continues to Help Drive Sales at Scale for the World's Leading Brands CHICAGO , Aug. 27, 2024 /PRNewswire/ -- Mavely , the Everyday Influencer Platform®, today announces remarkable achievements, underscoring its position as a rapidly growing player in the influencer marketing industry. With incredible growth and significant financial milestones in the first half of 2024, Mavely continues its momentum to empower people to monetize their content by promoting the world's favorite brands.

Nu Skin (NUS) Down 28% in 3 Months: What's the Next Best Move?
zacks.com20 August 2024 Sentiment: NEGATIVE

Nu Skin (NUS) has been battling persistent macroeconomic headwinds, which have been weighing on consumer spending and customer acquisition. Strong currency headwinds are also playing foul.

Why Nu Skin Enterprises Stock Flopped on Friday
fool.com09 August 2024 Sentiment: NEUTRAL

The cosmetics purveyor released its latest set of quarterly results. It beat on both revenue and profitability, but investors were more concerned about the future.

Nu Skin Enterprises, Inc. (NUS) Q2 2024 Earnings Call Transcript
seekingalpha.com08 August 2024 Sentiment: NEUTRAL

Nu Skin Enterprises, Inc. (NUS) Q2 2024 Earnings Call Transcript

Nu Skin (NUS) Set to Report Q2 Earnings: What to Expect?
zacks.com05 August 2024 Sentiment: NEUTRAL

Nu Skin's (NUS) Q2 results are likely to reflect the impacts of macroeconomic challenges, including inflation and adverse currency fluctuations.

  • 1(current)
  • 2

What type of business is Nu Skin Enterprises?

Nu Skin Enterprises, Inc. is a marketing company that produces products that not only help you look young at any age, but most importantly, maintain your health. In 1984, three young people, striving to create fundamentally new skincare products, founded the company in Provo, Utah (USA). Currently, the company's brands Nu Skin and Pharmanex include over 200 premium class products. Specializing in cosmetics, personal hygiene, dietary supplements, and the most advanced skin care devices. Special attention is paid to developments in ageLOC (anti-aging technologies), body shaping, and weight management. The main trade marks include Nu Skin, Pharmanex, ageLOC, LifePak, Galvanic Spa, TR90, Epoch, ageLOC Me, and LumiSpa.

What sector is Nu Skin Enterprises in?

Nu Skin Enterprises is in the Consumer Defensive sector

What industry is Nu Skin Enterprises in?

Nu Skin Enterprises is in the Household & Personal Products industry

What country is Nu Skin Enterprises from?

Nu Skin Enterprises is headquartered in United States

When did Nu Skin Enterprises go public?

Nu Skin Enterprises initial public offering (IPO) was on 22 November 1996

What is Nu Skin Enterprises website?

https://www.nuskin.com

Is Nu Skin Enterprises in the S&P 500?

No, Nu Skin Enterprises is not included in the S&P 500 index

Is Nu Skin Enterprises in the NASDAQ 100?

No, Nu Skin Enterprises is not included in the NASDAQ 100 index

Is Nu Skin Enterprises in the Dow Jones?

No, Nu Skin Enterprises is not included in the Dow Jones index

When was Nu Skin Enterprises the previous earnings report?

No data

When does Nu Skin Enterprises earnings report?

Next earnings report date is not announced yet